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A B S T R A C T
The aim of the study was to investigate the attitude change of general practitioners (GPs) in Bosnia and Herzegovina
considering the key decision points in the management of treatment of Helicobacter pylori (H. pylori)-associated diseases
in 2008, after the four-year period. The first survey was done from February to April 2004. Two hundred and sixty four
GPs in B&H responded to questionnaire especially designed for the study. In May 2008, four years after the first survey,
data were collected again by same questionnaire from 53 GPs. The most important source of information about the man-
agement of treatment of H. pylori-associated diseases in both surveys were symposia sponsored by pharmaceutical com-
panies, but the percent decreased from 53% in 2004 to 34% in 2008. The percent of GPs who named the Internet as the
major information source increased from 5% in 2004 to 28% in 2008. Medical journals were used as the most important
source of information by every fourth GP in 2008 almost in the same percent as in 2004. In 2008 the percent of GPs who
considered that the main obstacle to proper management of H. pylori-related diseases was the patient’s low income status
which was doubled in relation to 2004 (64%; 31% respectively). Almost all GPs (98%) claimed to eradicate H. pylori in
2008 – a significant increase compared to 2004 when 71% of GPs reported eradication. Sixty percent of GP in 2008
claimed confirmation of infection prior to prescribing the eradication therapy which was significant increase in compar-
ison to 2004 when only 9% of GPs confirmed presence of the H. pylori infection before starting eradication. All GPs who
claimed to eradicate H. pylori infection used a proton pump inhibitor based on triple drug therapy, while in 2004 18% of
GPs chose some other inadequate eradication therapy. As a conclusion, better selection of information sources eliminated
management options of questionable value, but scarce economic resources in B&H will probably remain the main obsta-
cle to the comprehensive H. pylori treatment.
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Introduction
The management of H. pylori-associated diseases is
now done by primary health care physicians, according
to world-wide adopted diagnostic and therapeutic proto-
cols. Information about H. pylori became common in
medical knowledge in Bosnia and Herzegovina (B&H) 5
years later than in the developed world, because of isola-
tion caused by war. The survey of attitudes and applied
algorithms in primary health care in B&H was done in
2004 so as to evaluate and correct the practice of general
practitioners (GPs)1.
Results of 2004 study showed that the most impor-
tant source of information about H. pylori management
to GPs in B&H were pharmaceutical industry sponsored
symposia; the major obstacle in implementation of diag-
nostic and therapeutic protocols was lack of inexpensive
and easy-to-get diagnostic test; 71% percent of GPs trea-
ted H. pylori infection in their practice; 18% of GPs pre-
scribed an inadequate, non-PPI-based triple drug regi-
men, and only 9% of those GPs who prescribed eradica-
tion therapy confirmed the presence of infection before
starting the eradication treatment.
According to what was said before, we concluded that
unacceptably high number of GPs treated their patients
in non-evidence based manner, using regimens of ques-
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tionable efficacy. So, we published our study in regional
medical journal to warn and change the practice of GPs’
attitudes.
As in primary health care (PHC) in B&H, only diag-
nostic device in 2004 was rapid urease test, contacts with
the managers of pharmaceuticals companies were made
to help purchasing new diagnostic devices. As a result,
other diagnostic methods, such as serology, histology and
urea breath test became available to GPs in B&H in
2008.
The aim of the study was identification of attitudes’
change in the management of Helicobacter pylori-associ-
ated diseases by GPs in B&H in 2008, four years after the
first survey.
Participants and Methods
Targeted population included the GPs who were wor-
king in Bosnia and Herzegovina in the primary health-
care. All participants were working in PHC. A question-
naire created to serve the purposes of this survey was
anonymous and consisted of 6 questions: information
source on the management of H. pylori; approach to H.
pylori eradication in H. pylori-associated diseases; the
most prominent obstacle to the proper management of
H. pylori-related diseases; approach to eradication of H.
pylori in everyday practice; H. pylori infection confirma-
tion before prescription of eradication therapy, and pre-
ferred eradication protocol.
Completing of the questionnaire took about 15 minutes.
Data were collected in two phases. Two hundred and
sixty four GPs responded from February to April 20041.
In May 2008 data were collected again by same question-
naire from 53 GPs.
Intergroup differences were compared using the c2-
-test. Degrees of freedom (df) were used. A p value of
<0.05 was considered statistically significant. Statistical
analyses were performed using Statistical Package for
the Social Sciences (SPSS) software for Windows.
Results
There was significant difference in considering im-
portance of information source between 2004 and 2008
(c2=30.8, df=3, p<0.001) (Table 1). Majority of GPs in-
terviewed in 2008 reported that the most important
source of information about the management of H. py-
lori-associated diseases were symposia and lectures spon-
sored by pharmaceutical companies, but the percent of
GPs decreased from 53% in 2004 to 34% in 2008 (c2=5.9,
df=1, p<0.015). The percent of GPs who named the
Internet as the major information source significantly in-
creased from 5% in 2004 to 28% in 2008 (c2=27.1, df=1,
p<0.001). In both 2008 and 2004 the least important
source of information was communication with local
gastroenterologist (11% and 14%, respectively) with no
statistically significant difference (c2=0.007, df=1,
p<0.932) Medical journals were used as the most impor-
tant source of information in 2008 by 26% of GPs, almost
in the same percent as in 2004 (28%) without significant
difference (c2=0.03, df=1, p<0.855).
Most GPs eradicated H. pylory in patients with ulcer
(96% in 2004, 74% in 2008), and there was significant dif-
ference in four-year interval (c2=27.1, df=1, p<0.001)
(Table 2). Percentage of those who eradicated H. pylori in
patients with gastro-oesophageal reflux disease (GERD)
increased in a small percent (from 42% in 2004 to 51% in
2008; c2=1.1, df=1, p=0.298), and to a statistically sig-
nificant higher degree in functional dyspepsia (from 21%
in 2004 to 47% in 2008; c2=14.9, df=1, p<0.001), and on
patients request (3% and 9% respectively; c2=14.4, df=1,
p<0.001), while there was no significant difference from
2004 to 2008 in percentage of GPs who eradicated H.
pylori in patients with gastric cancer in family history
(23% and 17% respectively; c2=0.6, df=1, p<0.424).
Sixty-four percent of GPs considered the patient’s low
income status as the main obstacle to proper manage-
ment of H. pylori-related diseases in 2008 (Table 3).
Compared to 2004 when 31% of GPs thought the same
that was a statistically significant increase (c2=21.9,
df=2, p<0.001). Thirty-six percent of GPs in 2008 found
that the lack of easy accessible diagnostic tests was the
major obstacle in H. pylori management, which was a sta-
tistically significant decrease compared to 2004 (c2=19.4,
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TABLE 1
THE MOST IMPORTANT SOURCE OF INFORMATION TO GENERAL PRACTITIONERS IN BOSNIA AND HERZEGOVINA ON THE
MANAGEMENT OF HELICOBACTER PYLORI-ASSOCIATED DISEASES
The most important source of information
2004. 2008.
N (% of GPs) n (% of GPs)
Sponsored symposia and lectures 141 (53%) 18 (34%)
Internet 13 (5%) 15 (28%)
Medical journals 76 (28%) 14 (26%)
Communication with local gastroenterologist 34 (14%) 6 (11%)
Total 264 (100%) 53 (100%)
n – number, GPs – general practitiones
df=1, p<0.001). Six percent of GPs in 2004 claimed that
lack of information about the management of H. pylori
infection was a serious obstacle to proper treatment,
while there were no GPs who claimed that in 2008
(c2=2.0, df=1, p<0.154).
Fifty-two GPs (98%) in 2008 claimed eradication of H.
pylori (Table 4) – a statistically significant increase com-
pared to 2004 (c2=15.9, df=1, p<0.001), when 71% of
GPs reported eradication therapy.
31 (60%) of those 52 GPs who claimed eradication of
H. pylori in their everyday practice in 2008 confirmed
the infection prior to prescribing the eradication therapy,
that is statistically significant increase (c2=62.0, df=1,
p<0.001 z=9.462, p<0.001), since in 2004 only 9% con-
firmed H. pylori infection before they started eradication
treatment (Table 5).
There was significant difference in eradication treat-
ment of H. pylori-related diseases used by GPs in 2004
and 2008 (c2=11.0, df=3, p<0.012) (Table 6). All 52 GPs
(100%) who claimed eradication of H. pylori infection in
everyday practice in 2008 considered a proton pump inhi-
bitor (PPI)-based triple therapy the treatment of choice
for their patients – a significant increase since 82% chose
the same therapy (c2=29.0, df=1, p<0.001 in 2004. In
2004 18% of GPs chose some other therapy as the first
choice (PPI-based double therapy 11%, histamine 2 re-
ceptor antagonist-based double treatment 5%, antimi-
crobial agents 2%).
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TABLE 3
GENERAL PRACTITIONERS OPINION ON THE MAIN OBSTACLE TO PROPER MANAGEMENT OF HELICOBACTER PYLORI–ASSOCI-
ATED DISEASES
General practitioners opinion main obstacle to management
2004 2008
N (% GP) n (% GP)
Patients financial inability to buy the prescribed drug 82 (31%) 34 (64%)
Lack of easy accessible diagnostic tests 167 (63%) 19 (36%)
Lack of information about Helicobacter pylori management 15 (6%) 0 (0%)
Total 264 (100%) 53 (100%)
n – number, GPs – general practitioners
TABLE 2
ERADICATION INDICATIONS OF HELICOBACTER PYLORI BY GENERAL PRACTITIONERS IN BOSNIA AND HERZEGOVINA
Eradication indications
2004 2008
n (% of GPs) n (% of GPs)
Ulcer 253 (96%) 39 (74%)
GERD 111 (42%) 27 (51%)
Functional dyspepsia 55 (21%) 25 (47%)
Patients with gastric can-
cer in family history
61 (23%) 9 (17%)
On patients request 7 (3%) 5 (9%)
n – number, GPs – general practitioners, GERD – gastroesophageal reflux disease
Note: multiple answers were allowed. Therefore sum of answers exceeded 100%
TABLE 4
GENERAL PRACTITIONERS IN BOSNIA AND HERZEGOVINA
WHO CLAIM TO ERADICATE HELICOBACTER PYLORI IN THEIR
PRACTICE
GPs who claim to
eradicate H. pylori
2004 2008
n (%) n (%)
Yes 188 (71%) 52 (98%)
No 76 (29%) 1 (2%)
Total 264 (100%) 53 (100%)
GPs – general practitioners, n – number
TABLE 5
CONFIRMATION OF HELICOBACER PYLORI INFECTION BE-
FORE PRESCRIBING ERADICATION THERAPY BY GENERAL
PRACTITIONERS IN BOSNIA AND HERZEGOVINA
Confirmation of H. pylori
infection by GPs
2004 2008
n (%) n (%)
Yes 17 (9%) 31 (60%)
No 171 (91%) 21 (40%)
Total 188 (100%) 52 (100%)
n – number, GPs – general practitioners
Discussion
Information sponsored by pharmaceutical industry is
the least relevant, as it could be biased. In 2008 it was
still the main source of information about H. pylori erad-
ication to GPs in B&H, but the change is obvious, as per-
cent of GPs informed in this way decreased from 53% in
2004 to 34% in 2008. The percent of GPs who primarily
searched the Internet increased from 5% in 2004 to 28%
in 2008. Medical journals, as the most relevant source of
information, were used only by 26% of GPs in 2008, al-
most in the same percent as in 2004. Most of GPs (74%)
in 2008 eradicated H. pylori in patients with ulcer, but to
a lower degree (96%) than in 2004. The reason is not
clear, but it could be explained by recent knowledge that
about 15% to 30% of gastric ulcers are related to use of
anti-inflammatory drugs, and not to H. pylori infection.
As world-wide accepted guidelines2 recommended eradi-
cation therapy in patients with peptic ulcer disease asso-
ciated with H. pylori and also in users of non steroidal
anti-inflammatory drugs who have peptic ulcer – the
same should be accepted in B&H.
Incomplete and inadequate implementation of guide-
lines for the management of H. pylori is not only present
in B&H but it is also world-wide phenomenon. According
to survey in USA3 only 59% of primary care physicians
eradicate H. pylori in patients with history of ulcer dis-
ease opposite to recommendation. Also, about 20% of pri-
mary care physicians do not read any of guidelines.
O’Connor4 in Ireland reported significant under-treat-
ment of eradication therapy in patients with peptic ulcer
disease by GPs as well as over-treatment in non-ulcer in-
dications. According to 2008 Hong-Kong study5 pub-
lished guidelines were not always and completely fol-
lowed in clinical practice.
The percentage of GPs who eradicated H. pylori in pa-
tients with functional dyspepsia significantly increased
in 2008. European Maastricht Consensus recommended
eradication therapy in infected patients with functional
dyspepsia2. Management of dyspepsia by GPs in Europe
is inconsistent and does not conform to existing evidence
based protocols6, and generally current guidelines for the
management of H. pylori infection were not implemen-
ted in practice7.
There are no clear guidelines for treatment on pa-
tients’ request, but three times more GPs in B&H eradi-
cated H. pylori on demand in 2008 than four years before
(9% and 3% respectively). There was no change from
2004 to 2008 in percentage of GPs who eradicated H.
pylori in patients with gastric cancer in family history
(23% and 18% respectively), although guidelines recom-
mended treatment for H. pylori in patients with first de-
gree relatives with gastric cancer.
Statistically significantly more GPs in B&H claimed
to confirm the infection prior to prescribing the eradica-
tion therapy in their everyday practice, as diagnostic
methods, serology, histology and urea breath test became
available in B&H in primary health care in 2008. This is
the same reason why much less GPs in 2008 than in 2004
considered the lack of easy accessible diagnostic tests as
the major obstacle in H. pylori management. It should be
stressed that pharmaceutical industry partially purcha-
sed the diagnostic equipment, and contributed to man-
agement change in H. pylori-associated disease of GPs in
B&H.
Two times more (64%) of GPs reported the patient’s
low income status as the main obstacle to proper man-
agement of H. pylori-related diseases. Evidently this was
a consequence of worsening of economic situation in
B&H. No GPs in 2008 claimed that lack of information
about the management of H. pylori infection was a seri-
ous obstacle to proper treatment.
Almost all GPs (98%) eradicated H. pylori, making
eradication treatment usual, everyday procedure in their
practice.
All 52 GPs who claimed to eradicate H. pylori infec-
tion considered a proton pump inhibitor (PPI)-based tri-
ple drug therapy to be the treatment of choice for their pa-
tients, while in 2004 18% of GPs chose some other obso-
lete non-(PPI)-based triple drug regimen as the first
choice.
We stated that better selection of information sources
improved the understanding of H. pylori-associated dis-
eases and partially changed the practice of primary health
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TABLE 6
ERADICATION TREATMENT OF HELICOBACTER PYLORI USED BY GENERAL PRACTITIONERS IN BOSNIA AND HERZEGOVINA
Treatment for H. pylori used by GPs in BH
2004 2008
n (%) n (%)
PPI-based triple therapy 154 (82%) 52 (100%)
PPI-based double therapy 21 (11%) 0 (0%)
H2RA-based double therapy 9 (5%) 0 (0%)
Antimicrobial agents 4 (2%) 0 (0%)
Total 188 (100%) 52 (100%)
GPs – general practitioners, n – number, BH – Bosnia and Herzegovina, PPI – proton pump inhibitor, H2RA – histamine 2 receptor an-
tagonist
care physicians through elimination of therapeutic op-
tions of questionable value, but scarce economic resour-
ces in B&H will probably remain the main obstacle to the
comprehensive H. pylori treatment. Further efforts should
be made through educational programmes in postgradu-
ate training centres, they have been actively planned,
but not realized in the last four years.
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TRETMAN BOLESTI UZROKOVANIH HELICOBACTEROM PYLORI: ISPITIVANJE PROMJENE
PRISTUPA U PRIMARNOJ ZDRAVSTVENOJ ZA[TITI U BOSNI I HERCEGOVINI NAKON
^ETVEROGODI[NJEG INTERVALA
S A @ E T A K
Cilj studije bio je identificiranje promjena pristupa lije~nika primarne zdravstvene za{tite u tretmanu bolesti uzro-
kovanih Helicobacterom pylori (H. pylori) 2008. godine; nakon ~etverogodi{njeg intervala. Dvije stotine {ezdeset lije-
~nika op}e prakse u Bosni i Hercegovini (BH) je odgovorilo na upitnik koji je namjenski ura|en za ovu studiju 2004.
godine. Nakon ~etiri godine podaci su ponovo prikupljeni istim upitnikom od 53 lije~nika op}e prakse. Naj~e{}i izvor
informacija o tretmanu bolesti koje su uzrokovane H. pylori su ponovo bili simpoziji uz potporu farmaceutskih tvrtki,
ali je postotak s 53% u 2004. godini smanjen na 34% u 2008. godini. Postotak lije~nika koji su naveli Internet kao glavni
informacijski izvor je pove}an s 5% u 2004 na 28% u 2008. godine. Medicinski ~asopisi su kori{teni kao najva`niji izvor
podataka u 2008. godini (28%) u gotovo istom postotku kao i u 2004. godini. Postotak lije~nika op}e prakse koji su dr`ali
da je glavna prepreka primjeni u svijetu prihva}enog dijagnosti~kog i terapijskog protokola H. pylori lo{e imovno stanje
bolesnika je dvostruko vi{a 2008. godine (64%) u odnosu na 2004. godinu (31%). Gotovo svi lije~nici op}e prakse (98%)
su lije~ili infekciju H. pylori 2008. godine, {to je zna~ajan porast u odnosu na 2004. godinu kada je to radilo 71%
lije~nika. [ezdeset posto lije~nika u 2008. godini je tra`ilo dokaz infekcije prije uvo|enja terapije iskorjenjivanjem, {to je
zna~ajan porast u odnosu na 2004. godini kada je dokaz tra`ilo 9% lije~nika. Svi lije~nici koji iskorjenjuju H. pylori
infekciju koriste trostruki tretman temeljen na inhibitoru protonske crpke, dok je 2004. godine 18% lije~nika biralo
neki drugi, neadekvatan terapijski pristup. Usporedbom pristupa u ~etverogodi{njem intervalu zaklju~eno je da je bolji
izbor informacijskog izvora iskorijenio terapijske opcije upitne vrijednosti, ali }e lo{a ekonomska situacija u BH vjero-
jatno ostati glavna prepreka primjerenom tretmanu H. pylori.
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